8-K: Centene Reaffirms 2024 EPS Guidance, Expects Shift in Earnings Between Quarters

Centene Corporation reaffirms its full-year 2024 adjusted diluted EPS guidance of greater than $6.80, while also noting a shift of 20 to 30 cents of EPS from Q3 to Q4.

Summary

• Centene Corporation's senior management team met with investors on September 10, 2024.
• The company reaffirmed its full-year 2024 adjusted diluted earnings per share (EPS) guidance of greater than $6.80.
• They also reiterated a shift of 20 to 30 cents of adjusted diluted EPS from the third quarter (Q3) to the fourth quarter (Q4).
• The company projects Q3 adjusted diluted EPS to be between $1.31 and $1.41.
• The remaining portion of the full-year adjusted diluted EPS is expected to be realized in Q4.
• Centene is encouraged by the progress made in improving its Medicare Advantage stars program performance.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the reaffirmation of full-year guidance and positive comments on the Medicare Advantage program, but the shift in earnings between quarters introduces a note of caution.

Positives

• The company has reaffirmed its full-year adjusted diluted EPS guidance, indicating confidence in its financial outlook.
• The company is making progress in its Medicare Advantage stars program, which could lead to improved performance and revenue.

Negatives

• There is a shift in earnings from Q3 to Q4, which may cause concern for investors expecting stronger Q3 results.

Risks

• The company's performance is subject to various risks, including competition, regulatory changes, and economic conditions.
• The company's ability to maintain or improve CMS Star ratings is crucial for revenue and future growth.
• The company's ability to accurately predict and manage health benefits and other operating expenses is critical.
• There are risks associated with business transactions, including acquisitions and divestitures.
• The company faces risks related to cyber-attacks and data security incidents.
• Changes in healthcare practices, new technologies, and advances in medicine could impact the company.
• The company's performance is subject to the effects of social, economic, and political conditions and geopolitical events.

Future Outlook

The company expects the majority of its 2024 full-year adjusted diluted EPS to be realized in Q4, following a shift from Q3. The company is encouraged by the progress in its Medicare Advantage stars program performance.

Management Comments

• The senior management team reaffirmed the company's 2024 full-year adjusted diluted EPS guidance.
• Management reiterated the shift of 20 to 30 cents of adjusted diluted EPS from Q3 to Q4.
• Management expressed encouragement regarding the progress in the Medicare Advantage stars program.

Industry Context

This announcement is relevant to the managed healthcare industry, where companies are closely monitored for their financial performance and ability to manage healthcare costs and quality. The focus on Medicare Advantage and star ratings is a key industry trend.

Comparison to Industry Standards

• Centene's reaffirmation of its EPS guidance is a positive sign, but the shift in earnings between quarters may be viewed cautiously by investors compared to peers who may have more consistent quarterly performance.
• Companies like UnitedHealth Group and Humana are often benchmarks in the managed care space, and their performance in Medicare Advantage and star ratings are closely watched.
• Centene's focus on improving its star ratings is consistent with industry-wide efforts to enhance quality and maximize revenue under government programs.
• The specific EPS figures and the shift between quarters will be compared to the performance of these and other competitors in the sector.

Stakeholder Impact

• Shareholders will be impacted by the reaffirmation of the EPS guidance and the shift in earnings between quarters.
• The company's performance in the Medicare Advantage program will impact its customers and their healthcare outcomes.
• The company's financial performance will impact its employees and their compensation.

Key Dates

Keywords

EPS, Earnings, Guidance, Medicare Advantage, Healthcare, Financial Performance, Centene, Stars Program